JOHNSON & JOHNSON
JNJNYSE🏆 #22 by market capEarnings Jan 20 · PreUS Equity
$271.04▲ $2.31 (+0.86%)
🌙 After hours$273.57▲ 0.93%Regular close · extended-hours price shownTrack JNJ
Get earnings, price moves & breaking news on Telegram
24h▲ 0.9%
7d▲ 5.2%
14d▲ 6.7%
30d▼ 0.4%
ytd▲ 31.0%
1y▲ 45.0%
🏦Market Cap
$652.48B
Large Cap
📈Revenue Growth (YoY)
7.8%
Slowing
📊Gross Margin
67.7%
High
💵FCF Margin
22.4%
Strong
⚖️P/S Ratio
6.4x
Fair
Otter Score
68
Fair
JOHNSON & JOHNSON
JNJAnalyst Ratings
Price
$271.04
Total
12
Raised
8
Lowered
3
Avg PT
$289.50
H / L
$320 / $263
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HSBC Johnson & Johnson | Raised | Buy | 2026-09-10 | $320.00 | +18.10% |
UBS Johnson & Johnson | Raised | Buy | 2026-09-02 | $320.00 | +18.10% |
Citigroup Johnson & Johnson | Raised | Buy | 2026-10-05 | $303.00 | +11.80% |
TD Cowen Johnson & Johnson | Raised | Buy | 2026-07-13 | $300.00 | +10.70% |
Morgan Stanley Johnson & Johnson | Lowered | Overweight | 2026-10-15 | $292.00 | +7.70% |
Wells Fargo Johnson & Johnson | Raised | Overweight | 2026-10-16 | $287.00 | +5.90% |
Guggenheim Johnson & Johnson | Reiterated | Buy | 2026-10-07 | $287.00 | +5.90% |
JP Morgan Johnson & Johnson | Raised | Neutral | 2026-09-29 | $285.00 | +5.20% |
RBC Capital Johnson & Johnson | Lowered | Outperform | 2026-10-14 | $280.00 | +3.30% |
Leerink Partners Johnson & Johnson | Lowered | Outperform | 2026-10-14 | $272.00 | +0.40% |
Raymond James Johnson & Johnson | Raised | Outperform | 2026-07-16 | $265.00 | −2.20% |
B of A Securities Johnson & Johnson | Raised | Neutral | 2026-07-10 | $263.00 | −3.00% |
Institution
HSBC
Raised · Buy · 2026-09-10
$320.00
+18.10%
UBS
Raised · Buy · 2026-09-02
$320.00
+18.10%
Citigroup
Raised · Buy · 2026-10-05
$303.00
+11.80%
TD Cowen
Raised · Buy · 2026-07-13
$300.00
+10.70%
Morgan Stanley
Lowered · Overweight · 2026-10-15
$292.00
+7.70%
Wells Fargo
Raised · Overweight · 2026-10-16
$287.00
+5.90%
Guggenheim
Reiterated · Buy · 2026-10-07
$287.00
+5.90%
JP Morgan
Raised · Neutral · 2026-09-29
$285.00
+5.20%
RBC Capital
Lowered · Outperform · 2026-10-14
$280.00
+3.30%
Leerink Partners
Lowered · Outperform · 2026-10-14
$272.00
+0.40%
Raymond James
Raised · Outperform · 2026-07-16
$265.00
−2.20%
B of A Securities
Raised · Neutral · 2026-07-10
$263.00
−3.00%
One row per institution · price target from the firm's latest published target